ProQR (PRQR) Prices 13.846M Share Common Offering at $6.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St futures recover as oil slides ahead of inflation test
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
After-Hours Stock Movers 03/30: (SURF) (CASI) (CHWY) Higher; (NMTR) (OSMT) (BB) Lower (more...)
March 30, 2021 5:42 PM EDTAfter-Hours Stock Movers:
Surface Oncology (Nasdaq: SURF) 14.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for one of the companys lead therapeutic candidates, SRF617, for the treatment of patients with pancreatic cancer.
ProQR (PRQR) Announces Proposed Underwritten Public Offering of Ordinary Shares
March 30, 2021 4:06 PM EDTProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced that it intends to offer and sell its ordinary shares in an underwritten public offering. All... More
